As chronic traumatic encephalopathy (CTE) stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical Systems Inc. for a first-of-its-kind study of cerebral microbleeds (CMB) in high school football players as a potential precursor to CTE.

Physicians have begun treating patients with the Mevion S250 proton therapy system at The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center-Orlando Health in Florida.

Focal Therapeutics, makers of the three-dimensional BioZorb implant used in breast conservation therapy, announced it has launched BioZorb LP.

The intersection between PET/CT and radiation therapy is widening. And it is doing so in unanticipated ways.

The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022, according to research and consulting firm GlobalData. This represents a compound annual growth rate of 4.9 percent.

Lung ultrasound has been shown to be highly effective and safe for diagnosing pneumonia in children and a potential substitute for chest X-ray, according to a study conducted at the Icahn School of Medicine at Mount Sinai.

The U.S. Food and Drug Administration (FDA) has received a small number of reports of adverse events that are believed to be associated with computed tomography (CT) imaging of some implantable and wearable electronic devices.

April 13, 2016 — Fujifilm Medical Systems U.S.A. Inc. sponsored the keynote presentation at the National Consortium of Breast Centers (NCoBC) 2016 conference delivered by Nancy M. Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy Inc. Fujifilm also showcased its Aspire Cristalle mammography system at the conference, April 9-13 in Las Vegas.

Using positron emission tomography (PET) to guide chemotherapy treatment significantly increases the number of people with advanced Hodgkin lymphoma who go into remission, according to new research.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now